US BROKER MOVES: JBHT upgraded at Citizens; PTON downgraded at Morgan Stanley

UPGRADES Haemonetics (HAE) Upgraded from Neutral to Buy at Citi HAWK (HAWK) Upgraded from Neutral to Buy at BofA Securities; PT USD 23 J.B. Hunt Transport Services (JBHT) Upgraded from Market Perform to Market Outperform at Citizens; PT USD 300 DOWNGRADES Boston Scientific (BSX) Downgraded from Buy to Neutral at Citi Fluence Energy (FLNC) Downgraded from Buy to Neutral at Goldman Sachs; PT USD 9 Lyft (LYFT) Downgraded from Buy to Neutral at Guggenheim; PT USD 16 Okta (OKTA) Downgraded from Outperform to Market Perform at Bernstein SocGen Group; PT USD 174 Palo Alto Networks (PANW) Downgraded from Outperform to Market Perform at Bernstein SocGen Group; PT USD 351 Pegasystems (PEGA) Downgraded from Overweight to Neutral at JPMorgan; PT USD 47 Peloton (PTON) Downgraded from Equalweight to Underweight at Morgan Stanley; PT USD 4.50 SentinelOne (S) Downgraded from Outperform to Market Perform at Bernstein SocGen Group; PT USD 25 INITIATIONS Abeona Therapeutics (ABEO) Initiated at Buy at Roth/MKM; PT USD 17 Applied Digital (APLD) Initiated at Overweight at Wells Fargo; PT USD 50 Assured Guaranty (AUGO) Initiated at Sector Outperform at Scotiabank; PT USD 110 Celcuity (CELC) Initiated at Overweight at JPMorgan; PT USD 157 Cipher Mining (CIFR) Initiated at Overweight at Wells Fargo; PT USD 25 Core Scientific (CORZ) Initiated at Overweight at Wells Fargo; PT USD 28 Crescent Energy (CRGY) Initiated at Buy at Truist Securities; PT USD 19 Comstock Resources (CRK) Initiated at Hold at Truist Securities; PT USD 16 First Horizon (FHN) Initiated at Market Perform at Hovde Group; PT USD 25 GRAIL (GRAL) Initiated at Sector Perform at RBC Capital; PT USD 84 Herbalife (HLF) Initiated at Buy at Texas Capital Securities; PT USD 21 Honeywell Aerospace (HONA) Initiated at Positive at Susquehanna; PT USD 190 iBio (IBIO) Initiated at Buy at H.C. Wainwright; PT USD 7 Kraft Heinz (KHC) Initiated at Outperform at RBC Capital; PT USD 32 Kopin (KOPN) Initiated at Outperform at Oppenheimer; PT USD 7 Kyntra Bio (KYNB) Initiated at Buy at Lake Street; PT USD 41 Mira Pharmaceuticals (MIRA) Initiated at Buy at Maxim Group; PT USD 3.50 MediciNova (MNOV) Initiated at Buy at Roth/MKM; PT USD 6 Octave Intelligence (OCTV) Initiated at Equalweight at Morgan Stanley; PT USD 21 Pandora (P) Initiated at Buy at Needham; PT USD 140 Paymentus (PAY) Initiated at Buy at Seaport Global Securities; PT USD 42 Prenetics (PRE) Initiated at Buy at Craig-Hallum; PT USD 40 Prelude Therapeutics (PRLD) Initiated at Overweight at JPMorgan; PT USD 12 Paramount Skydanc (PSKY) Initiated at Underweight at Barclays; PT USD 8 Red Violet (RDVT) Initiated at Outperform at Raymond James; PT USD 90 SiTime (SITM) Initiated at Overweight at Morgan Stanley; PT USD 730 Soluna (SLNH) Initiated at Buy at Rosenblatt; PT USD 4 Spruce Biosciences (SPRB) Initiated at Buy at Lake Street; PT USD 149 T1 Energy (TE) Initiated at Hold at Vertical Research Partners; PT USD 5 Telomir Pharmaceuticals (TELO) Initiated at Buy at Maxim Group; PT USD 4 Alpha Teknova (TKNO) Initiated at Buy at Jefferies; PT USD 9 Taysha Gene Therapies (TSHA) Initiated at Outperform at Wolfe Research VF Corp (VFC) Initiated at Hold at Deutsche Bank; PT USD 14 Verastem (VSTM) Initiated at Outperform at Wolfe Research Warner Bros Discovery (WBD) Initiated at Equalweight at Barclays; PT USD 29 Western Midstream (WES) Initiated at Buy at Truist Securities; PT USD 55 TeraWulf (WULF) Initiated at Overweight at Wells Fargo; PT USD 30 Zymeworks (ZYME) Initiated at Outperform at Wolfe Research